Fascia Iliaca Compartment Block in Acute and Chronic Pain Management in Hip Fracture Patients

Asklepieion Voulas General Hospital

Status: Completed

Conditions: Chronic Hip Pain

Treatments: Device: ultrasound; Drug: Placebo; Drug: Fascia iliaca compartment block; Drug: Ropivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT02479828

7533 (Other Identifier)

Details and patient eligibility

About

This study evaluates the effect of fascia iliaca compartment block (FICB) in the management of acute post -surgical pain in hip fracture patients and in the appearance of chronic post -surgical hip pain, by means of von Korff Graded Chronic Pain Scale -modified for hip pain in Greek.

Half of the patients will not receive fascia iliaca compartment block.

Enrollment: 198 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA I-III (American Society of Anesthesiologists classification)
• intertrochanteric fractures
• fractures of femoral neck

Exclusion criteria

• existing pain in hip Joint to be operated
• cognitive or mental disorder
• administration of analgesic drugs prior surgery
• contraindications of spinal anesthesia
• refusal to participate in the study

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

198 participants in 2 patient groups, including a placebo group

Fascia iliaca compartment block (FICB)

Active Comparator group

Description:

Under ultrasound guidance performing fascia iliaca compartment block, in which 40 ml ropivacaine 0,5% are injected under the fascia iliaca.

Treatment:

Device: ultrasound

Drug: Fascia iliaca compartment block

Drug: Ropivacaine

Placebo (not FICB)

Placebo Comparator group

Description:

Half of the patients will not receive FICB

Treatment:

Drug: Placebo